nifedipine has been researched along with nicorandil in 53 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (45.28) | 18.7374 |
| 1990's | 17 (32.08) | 18.2507 |
| 2000's | 7 (13.21) | 29.6817 |
| 2010's | 5 (9.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aisaka, K; Cho, H; Kajimoto, Y; Katoh, S; Kawasaki, H; Murakami, K; Nakanishi, H; Sayama, S; Uchida, I; Ueno, H | 1 |
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Berdeaux, A; Drieu la Rochelle, C; Giudicelli, JF; Richard, V | 1 |
| Auchampach, JA; Gross, GJ; Maruyama, M; Pieper, GM; Warltier, DC | 1 |
| Diderholm, E; Frithz, G; Gudbrandsson, T; Hedbäck, B; Höglund, C; Moelstad, P; Perk, J; Sverrisson, JT; Ulvenstam, G | 1 |
| Bauters, C; Bertrand, ME; Lablanche, JM; Leroy, F | 1 |
| Fukata, Y; Fukushima, H; Jinno, Y; Kaneta, S; Nishikori, K; Ogawa, N | 1 |
| Satoh, E; Taira, N; Yanagisawa, T | 1 |
| Akiyama, H; Kobayashi, I; Kobayashi, S; Mori, M; Shiono, S; Yamada, M; Yamaguchi, M | 1 |
| Kato, A; Nakamura, F; Sugimoto, T; Sumino, S; Tomaru, T; Uchida, Y | 1 |
| Gross, GJ; Hardman, HF; Warltier, DC | 1 |
| Imai, S; Katano, Y; Nabata, H; Nakagawa, Y; Nakazawa, M; Takeda, K; Tsukada, T; Ushijima, T | 1 |
| Hakuta, T; Kobayashi, K | 1 |
| Sugimoto, T; Uchida, Y | 1 |
| Ishii, K; Sato, Y; Taira, N | 1 |
| Hashimoto, H; Taira, N; Yanagisawa, T | 2 |
| Fujimoto, M; Kitao, T; Kohara, H; Kumahara, Y; Morimoto, K; Ogihara, T; Ohde, H; Tai, H; Terada, K | 1 |
| Hester, RK | 1 |
| Flores, F; Hester, RK; Satake, N; Shibata, S; Ueda, S | 1 |
| Brooks, HL; Gross, GJ; Warltier, DC; Wynsen, JC | 1 |
| Imai, S; Matsui, K; Ogawa, Y | 1 |
| Hader, S; Leitold, M | 1 |
| Araki, H; Hayata, N; Matsuguchi, T; Nakamura, M | 1 |
| Clapham, JC; Wilson, C | 1 |
| Hashimoto, T; Kaguchi, Y; Kimura, M; Kuriyama, S; Miyahara, T; Nakamura, K; Tamai, K; Tamura, H | 1 |
| Uchida, Y | 1 |
| Ishii, K; Satoh, K; Taira, N; Yanagisawa, T | 1 |
| Imai, S; Nabata, H; Nakazawa, M; Sakai, K; Ushijima, T | 1 |
| Gross, GJ; Hardman, HF; Lamping, KA; Warltier, DC | 1 |
| Hirakawa, S; Ito, H | 1 |
| Kerfoot, F; Satake, N; Shibata, S; Suh, TK; Takagi, T | 1 |
| Fukata, Y; Fukushima, H; Harada, K; Jinno, Y; Kaneta, S; Ogawa, N | 1 |
| Fukushima, H; Jinno, Y; Kaneta, S; Miwa, A; Ogawa, N | 1 |
| Masuda, Y; Tanaka, S; Yamashita, T | 1 |
| Fukata, Y; Fukushima, H; Harada, K; Kaneta, S; Miwa, A; Ogawa, N | 1 |
| Angus, JA; Fujiwara, T | 1 |
| Murayama, S; Nakano, T; Yamakado, T | 1 |
| Houchi, H; Nakaya, Y; Oka, M; Shono, M | 1 |
| Araki, H; Higuchi, S; Noguchi, K; Takahashi, K | 1 |
| Aisaka, K; Hirata, Y; Mabuchi, Y; Miyai, H | 1 |
| Aisaka, K; Hirata, Y; Kanada, A; Mabuchi, Y; Miyai, H | 1 |
| Ikegaki, I; Sasaki, Y; Uchida, T; Yamamoto, Y | 1 |
| Matsui, K; Ohashi, N; Sasabe, M; Yamamoto, S | 1 |
| Hirai, M; Iino, S; Kondo, T; Takeshita, K; Tanaka, T | 1 |
| Chan, P; Cheng, JT; Liu, IM; Tzeng, TF; Wong, KL; Yang, TL | 1 |
| Beguier, B; Wajima, T; Yaguchi, M | 1 |
| Kawamura, K; Maehara, K; Maruyama, Y; Mizugami, H; Sakamoto, N; Ujiie, Y; Yamaki, T; Yaoita, H | 1 |
| Chen, Y; Dai, R; Deng, Y; Lao, X; Li, Y; Meng, W; Sheng, L; Wu, C | 1 |
| Dawood, R; Masood, A; Rezk, M; Sayyed, T | 1 |
| Gao, G; Guo, D; Li, YX; Liu, H; Liu, Y; Nasir, A; Ruzi, A; Wu, F; Xu, G; Yang, F | 1 |
4 trial(s) available for nifedipine and nicorandil
| Article | Year |
|---|---|
Antianginal and anti-ischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease: a double-blind, randomized, multicenter study.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Double-Blind Method; Electrocardiography; Exercise; Female; Heart Rate; Humans; Male; Middle Aged; Niacinamide; Nicorandil; Nifedipine; Potassium Channels; Tablets | 1992 |
Prevention of coronary spasm by nicorandil: comparison with nifedipine.
Topics: Administration, Oral; Adult; Coronary Vasospasm; Double-Blind Method; Ergonovine; Humans; Middle Aged; Niacinamide; Nicorandil; Nifedipine; Vasodilator Agents | 1992 |
Effects of nicorandil, an antianginal potassium channel opener, on left ventricular systolic and diastolic function in patients with chronic coronary artery disease.
Topics: Adult; Aged; Chronic Disease; Coronary Disease; Diastole; Female; Humans; Male; Middle Aged; Niacinamide; Nicorandil; Nifedipine; Nitroglycerin; Potassium Channels; Systole; Vasodilator Agents; Ventricular Function, Left; Ventricular Pressure | 1997 |
RETRACTED: Nicorandil vs nifedipine for the treatment of preterm labour: a randomized clinical trial.
Topics: Adolescent; Adult; Double-Blind Method; Female; Fetal Diseases; Headache; Humans; Nicorandil; Nifedipine; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications, Cardiovascular; Tachycardia; Tocolytic Agents; Treatment Outcome; Young Adult | 2015 |
49 other study(ies) available for nifedipine and nicorandil
| Article | Year |
|---|---|
Synthesis and selective coronary vasodilatory activity of 3,4-dihydro-2,2-bis(methoxymethyl)-2H-1-benzopyran-3-ol derivatives: novel potassium channel openers.
Topics: Animals; Benzopyrans; Blood Pressure; Coronary Circulation; Coronary Vessels; Dogs; Female; Heart Rate; Ion Channel Gating; Male; Models, Molecular; Molecular Structure; Potassium Channels; Pyridazines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Swine; Vasodilator Agents | 1996 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Differential effects of nitrovasodilators, K(+)-channel openers, and nicorandil on large and small coronary arteries in conscious dogs.
Topics: Animals; Benzopyrans; Coronary Vessels; Cromakalim; Dogs; Dose-Response Relationship, Drug; Injections, Intravenous; Molsidomine; Niacinamide; Nicorandil; Nifedipine; Nitroglycerin; Potassium Channels; Pyrroles; Vasodilation; Vasodilator Agents | 1992 |
Cardioprotective effects of nicorandil.
Topics: Animals; Benzopyrans; Coronary Circulation; Dihydropyridines; Dogs; Female; Heart; In Vitro Techniques; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Neutrophils; Niacinamide; Nicorandil; Nifedipine; Potassium Channels; Rats; Rats, Sprague-Dawley; Reperfusion; Superoxides | 1992 |
Comparison of KRN2391 with nicorandil and nifedipine on canine coronary blood flow: antagonism by glibenclamide.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Coronary Circulation; Dogs; Dose-Response Relationship, Drug; Female; Glyburide; Heart Rate; Male; Niacinamide; Nicorandil; Nifedipine; Potassium Channels; Pyridines; Vascular Resistance | 1992 |
Specific antagonism by glibenclamide of negative inotropic effects of potassium channel openers in canine atrial muscle.
Topics: Animals; Benzopyrans; Carbachol; Cromakalim; Dogs; Female; Glyburide; Guanidines; Heart Atria; Male; Myocardial Contraction; Niacinamide; Nicorandil; Nifedipine; Pinacidil; Potassium Channels; Pyrroles; Vasodilator Agents | 1990 |
Thyrotropin-releasing hormone stimulation of thyrotropin secretion is suppressed by calcium ion antagonists that block transmembrane influx and intracellular mobilization of calcium ion in human subjects.
Topics: Adult; Calcium; Calcium Channel Blockers; Humans; Ion Channels; Male; Niacinamide; Nicorandil; Nifedipine; Thyrotropin; Thyrotropin-Releasing Hormone | 1986 |
Phasic contractions of canine and human coronary arteries induced by potassium channel blockers.
Topics: 4-Aminopyridine; Adult; Aged; Amifampridine; Aminopyridines; Angina Pectoris, Variant; Animals; Arteries; Coronary Vasospasm; Coronary Vessels; Dogs; Female; Humans; Ion Channels; Macaca mulatta; Male; Middle Aged; Models, Biological; Muscle, Smooth, Vascular; Niacinamide; Nicorandil; Nifedipine; Swine; Tetraethylammonium Compounds; Vasoconstriction | 1986 |
Comparative effects of nicorandil, a nicotinamide nitrate derivative, and nifedipine on myocardial reperfusion injury in dogs.
Topics: Animals; Blood Pressure; Coronary Circulation; Dogs; Female; Male; Myocardial Contraction; Myocardial Infarction; Niacinamide; Nicorandil; Nifedipine | 1987 |
Effects of nicorandil on the conductive coronary artery of the dog.
Topics: Animals; Coronary Vessels; Dogs; Female; In Vitro Techniques; Lanthanum; Male; Muscle, Smooth, Vascular; Niacinamide; Nicorandil; Nifedipine; Nitroglycerin; Perfusion; Potassium; Vasoconstriction; Vasodilator Agents | 1987 |
Effects of nicorandil on coronary hemodynamics in ischemic heart disease: comparison with nitroglycerin, nifedipine, and propranolol.
Topics: Adult; Aged; Cardiac Pacing, Artificial; Coronary Circulation; Coronary Disease; Hemodynamics; Humans; Lactates; Lactic Acid; Middle Aged; Myocardium; Niacinamide; Nicorandil; Nifedipine; Nitroglycerin; Norepinephrine; Oxygen Consumption; Propranolol; Vasodilator Agents | 1987 |
The effects of nicorandil on phasic contractions of isolated canine coronary artery.
Topics: 4-Aminopyridine; Amifampridine; Aminopyridines; Animals; Calmodulin; Coronary Vessels; Dogs; Ergonovine; In Vitro Techniques; Membrane Potentials; Muscle Contraction; Niacinamide; Nicorandil; Nifedipine; Nitroglycerin; Vasodilator Agents | 1987 |
Differential antagonism by Bay K 8644 of vasodilator effects of nifedipine, diltiazem, nicorandil and nitroglycerin in dog femoral circulation.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Diltiazem; Dogs; Dose-Response Relationship, Drug; Female; Femoral Artery; Femur; Male; Niacinamide; Nicorandil; Nifedipine; Nitroglycerin; Regional Blood Flow; Vasodilator Agents | 1988 |
Interaction of potassium channel openers and blockers in canine atrial muscle.
Topics: Animals; Barium; Barium Compounds; Chlorides; Dogs; Female; Guanidines; Heart; In Vitro Techniques; Male; Myocardial Contraction; Myocardium; Niacinamide; Nicorandil; Nifedipine; Pinacidil; Potassium Channels; Quaternary Ammonium Compounds; Tetraethylammonium Compounds | 1989 |
Effects of the kallikrein-kinin system on phasic coronary vasospasm in dogs.
Topics: Animals; Bradykinin; Coronary Vasospasm; Coronary Vessels; Diltiazem; Dogs; Female; In Vitro Techniques; Kallikreins; Male; Niacinamide; Nicorandil; Nifedipine; Vasoconstriction; Vasodilator Agents | 1989 |
Effects of 2-nicotinamidoethyl nitrate on agonist-sensitive Ca++ release and Ca++ entry in rabbit aorta.
Topics: Animals; Aorta; Biological Transport; Calcium; Female; Gallopamil; Ion Channels; Male; Membrane Potentials; Muscle Contraction; Muscle, Smooth, Vascular; Niacinamide; Nicorandil; Nifedipine; Norepinephrine; Potassium Chloride; Rabbits | 1985 |
The negative inotropic effect of nicorandil is independent of cyclic GMP changes: a comparison with pinacidil and cromakalim in canine atrial muscle.
Topics: Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Benzopyrans; Cromakalim; Cyclic AMP; Cyclic GMP; Dogs; Female; Guanidines; In Vitro Techniques; Male; Monoamine Oxidase Inhibitors; Myocardial Contraction; Myocardium; Niacinamide; Nicorandil; Nifedipine; Pinacidil; Potassium Channels; Pyrroles; Tetraethylammonium Compounds; Vasodilator Agents | 1988 |
Effect of nicorandil, N-(2-hydroxyethyl)nicotinamide nitrate, a new anti-anginal agent, on contractile responses to alpha-1- and alpha-2-adrenoceptor agonists in isolated rabbit aorta.
Topics: Adrenergic alpha-Agonists; Animals; Aorta; Azepines; Clonidine; Male; Methoxamine; Niacinamide; Nicorandil; Nifedipine; Rabbits; Vasodilation | 1986 |
Differential effects of nifedipine, nicorandil and nitroglycerin on the pressor responses elicited by selective alpha-1 and alpha-adrenoceptor agonists in conscious dogs.
Topics: Adrenergic alpha-Agonists; Animals; Azepines; Blood Pressure; Dogs; Female; Hemodynamics; Male; Niacinamide; Nicorandil; Nifedipine; Nitroglycerin; Phenylephrine; Vasodilator Agents | 1987 |
Relaxant effects of pinacidil, nicorandil, hydralazine and nifedipine as studied in the porcine coronary artery and guinea-pig taenia coli.
Topics: Animals; Caffeine; Colon; Coronary Vessels; Female; Guanidines; Guinea Pigs; Hydralazine; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth; Muscle, Smooth, Vascular; Niacinamide; Nicorandil; Nifedipine; Pinacidil; Potassium; Swine; Vasodilator Agents | 1986 |
[Influence of antianginal drugs on Lypressin induced T-wave enhancement in the electrocardiogram of the rat].
Topics: Administration, Oral; Angina Pectoris; Animals; Coronary Vasospasm; Electrocardiography; Hypoxia; Isosorbide Dinitrate; Lypressin; Male; Molsidomine; Niacinamide; Nicorandil; Nifedipine; Nitroglycerin; Rats; Rats, Inbred Strains; Verapamil | 1986 |
Effects of nicorandil on rest and effort angina unresponsive to combination therapy with a calcium antagonist and oral nitrate.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Diltiazem; Drug Resistance; Drug Therapy, Combination; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Niacinamide; Nicorandil; Nifedipine; Physical Exertion; Prospective Studies; Rest; Vasodilator Agents | 1987 |
Anti-spasmogenic and spasmolytic effects of BRL 34915: a comparison with nifedipine and nicorandil.
Topics: Animals; Benzopyrans; Cromakalim; Electric Stimulation; In Vitro Techniques; Male; Mesenteric Arteries; Muscle Contraction; Muscle, Smooth, Vascular; Niacinamide; Nicorandil; Nifedipine; Norepinephrine; Parasympatholytics; Potassium Chloride; Pyrroles; Rabbits | 1987 |
The effects of vasoactive agents on the proliferation of vascular smooth muscle cells grown in vitro.
Topics: Amiloride; Animals; Captopril; Cell Division; Cells, Cultured; Chlorpromazine; In Vitro Techniques; Labetalol; Muscle, Smooth, Vascular; Niacinamide; Nicorandil; Nifedipine; Norepinephrine; Propranolol; Quinazolines; Rats; Sulfonamides | 1988 |
Decreasing potassium conductance--a possible mechanism of phasic coronary vasospasm.
Topics: 4-Aminopyridine; Amifampridine; Aminopyridines; Animals; Calcium; Coronary Vasospasm; Coronary Vessels; Dogs; Ergonovine; Female; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Macaca mulatta; Male; Membrane Potentials; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Myocardium; Niacinamide; Nicorandil; Nifedipine; Potassium; Swine; Tetraethylammonium; Tetraethylammonium Compounds | 1985 |
Abolition of spontaneous rhythmic contractions of isolated monkey coronary arteries by diltiazem, nifedipine, verapamil and nicorandil but not by nitroglycerin.
Topics: Animals; Calcium Channel Blockers; Coronary Vessels; Diltiazem; Erythrocebus patas; Female; In Vitro Techniques; Macaca mulatta; Male; Muscle Contraction; Muscle, Smooth, Vascular; Niacinamide; Nicorandil; Nifedipine; Nitroglycerin; Verapamil | 1985 |
Mechanism of relaxant effects of nicorandil on the dog coronary artery.
Topics: Animals; Caffeine; Calcium; Coronary Vessels; Dogs; Female; Lanthanum; Male; Niacinamide; Nicorandil; Nifedipine; Nitroglycerin; Potassium; Vasoconstriction; Vasodilation; Vasodilator Agents | 1983 |
Effects of nicorandil, a new antianginal agent, and nifedipine on collateral blood flow in a chronic coronary occlusion model.
Topics: Animals; Collateral Circulation; Coronary Circulation; Coronary Disease; Disease Models, Animal; Dogs; Female; Hemodynamics; Male; Niacinamide; Nicorandil; Nifedipine; Vasodilator Agents | 1984 |
Effects of vasodilators on the systemic capacitance vessels, a study with the measurement of the mean circulatory pressure in dogs.
Topics: Animals; Blood Pressure; Blood Vessels; Blood Volume; Cardiac Output; Diltiazem; Dogs; Heart Rate; Isosorbide Dinitrate; Molsidomine; Niacinamide; Nicorandil; Nifedipine; Nitroglycerin; Prazosin; Sydnones; Trapidil; Vascular Resistance; Vasodilator Agents; Venous Pressure; Verapamil | 1984 |
Relaxing effect of nicorandil (N-2-(hydroxyethyl)-nicotinamide nitrate), a new anti-angina agent, on the isolated vascular smooth muscle.
Topics: Animals; Aorta, Thoracic; Basilar Artery; Calcium; Cats; Coronary Vessels; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Niacinamide; Nicorandil; Nifedipine; Nitroglycerin; Norepinephrine; Potassium Chloride; Rabbits; Vasodilator Agents | 1984 |
Hemodynamic profile of KRN2391, a novel vasodilator, in anesthetized dogs.
Topics: Anesthesia; Animals; Blood Pressure; Cerebrovascular Circulation; Coronary Circulation; Dogs; Female; Heart Rate; Hemodynamics; In Vitro Techniques; Injections, Intra-Arterial; Injections, Intravenous; Male; Niacinamide; Nicorandil; Nifedipine; Pyridines; Regional Blood Flow; Renal Circulation; Splanchnic Circulation; Vascular Resistance; Vasodilator Agents | 1993 |
Effect of KRN2391 on venous return: comparison with other vasodilators.
Topics: Animals; Benzopyrans; Cromakalim; Dogs; Female; Glyburide; Hemodynamics; Male; Niacinamide; Nicorandil; Nifedipine; Nitroglycerin; Potassium Channels; Pyridines; Pyrroles; Vasodilator Agents; Veins | 1993 |
Potassium channel openers relax A23187-induced nifedipine-resistant contraction of rat aorta.
Topics: Animals; Aorta; Benzopyrans; Calcimycin; Cromakalim; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Niacinamide; Nicorandil; Nifedipine; Oxadiazoles; Piperidines; Pyrroles; Rats; Rats, Wistar; Vasoconstriction; Vasodilator Agents | 1994 |
Effect of KRN2391, a novel vasodilator, on various experimental anginal models in rats.
Topics: Angina Pectoris; Animals; Disease Models, Animal; Electrocardiography; Injections, Intravenous; Isoproterenol; Male; Methacholine Chloride; Niacinamide; Nicorandil; Nifedipine; Pyridines; Rats; Rats, Wistar; Vasodilator Agents | 1993 |
Analysis of relaxation and repolarization mechanisms of nicorandil in rat mesenteric artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Benzopyrans; Calcium Channel Blockers; Cromakalim; Electrophysiology; Glyburide; Hypoglycemic Agents; In Vitro Techniques; Male; Membrane Potentials; Mesenteric Arteries; Methylene Blue; Muscle Relaxation; Muscle, Smooth, Vascular; Niacinamide; Nicorandil; Nifedipine; Potassium Channels; Prostaglandin Endoperoxides, Synthetic; Pyrroles; Rats; Rats, Sprague-Dawley; Thromboxane A2; Vasoconstrictor Agents; Vasodilator Agents | 1996 |
Effects of nitroprusside and nicorandil on catecholamine secretion and calcium mobilization in cultured bovine adrenal chromaffin cells.
Topics: Adrenal Medulla; Animals; Calcium; Catecholamines; Cattle; Cells, Cultured; Chromaffin Cells; Glyburide; Niacinamide; Nicorandil; Nifedipine; Nitroprusside; Vasodilator Agents | 1997 |
Vasodilation profile of CD-832, a novel dihydropyridine derivative in rabbit aorta.
Topics: Adrenergic alpha-Agonists; Animals; Aorta, Thoracic; Calcium Channel Blockers; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Niacinamide; Nicorandil; Nifedipine; Nitrendipine; Nitroglycerin; Norepinephrine; Potassium Chloride; Rabbits; Vasodilation; Vasodilator Agents | 1997 |
Effect of JTV-506, a novel vasodilator, on experimental angina model in rats.
Topics: Administration, Oral; Angina Pectoris; Animals; Arginine Vasopressin; Blood Pressure; Chromans; Cromakalim; Dose-Response Relationship, Drug; Electrocardiography; Heart Rate; Injections, Intravenous; Male; Methacholine Chloride; Molecular Structure; Niacinamide; Nicorandil; Nifedipine; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents; Vasodilator Agents | 1998 |
Effects of the new potassium channel opener JTV-506 on coronary vessels in vitro and in vivo.
Topics: Anesthesia; Animals; Chromans; Coronary Circulation; Coronary Vessels; Cromakalim; Dogs; Female; In Vitro Techniques; Male; Nicorandil; Nifedipine; Nitroglycerin; Potassium Channels; Swine; Vasodilator Agents | 1999 |
The protein kinase inhibitor fasudil protects against ischemic myocardial injury induced by endothelin-1 in the rabbit.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Cell Movement; Diltiazem; Electrocardiography; Endothelin-1; Enzyme Inhibitors; Heart Ventricles; Macrophages; Male; Microscopy; Myocardial Ischemia; Necrosis; Neutrophils; Nicorandil; Nifedipine; Papillary Muscles; Rabbits; Random Allocation; Vasodilator Agents | 2000 |
Effect of an orally active Na+/H+ exchange inhibitor, SMP-300, on experimental angina and myocardial infarction models in rats.
Topics: Administration, Oral; Angina Pectoris; Animals; Azocines; Coronary Disease; Electrocardiography; Isoproterenol; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nicorandil; Nifedipine; Propranolol; Pyrroles; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sodium-Hydrogen Exchangers; Vasodilator Agents; Vasopressins | 2002 |
The effects of vasodilators on the relaxation of guinea-pig aorta during acute recoil.
Topics: Adrenergic alpha-Antagonists; Amlodipine; Angioplasty, Balloon, Coronary; Animals; Aorta, Thoracic; Disease Models, Animal; Female; Guinea Pigs; In Vitro Techniques; Isometric Contraction; Isosorbide Dinitrate; Muscle Relaxation; Muscle, Smooth, Vascular; Nicorandil; Nifedipine; Phentolamine; Platelet Aggregation Inhibitors; Postoperative Complications; Succinates; Vasodilator Agents | 2002 |
Antihyperglycemic action of angiotensin II receptor antagonist, valsartan, in streptozotocin-induced diabetic rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Glucose; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Gene Expression; Glucose Tolerance Test; Glucose Transporter Type 4; Hyperglycemia; Liver; Male; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Nicorandil; Nifedipine; Phosphoenolpyruvate Carboxykinase (GTP); Rats; Rats, Wistar; RNA, Messenger; Saralasin; Tetrazoles; Valine; Valsartan | 2003 |
Effects of cariporide (HOE642) on myocardial infarct size and ventricular arrhythmias in a rat ischemia/reperfusion model: comparison with other drugs.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Dose-Response Relationship, Drug; Electrocardiography; Guanidines; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Nicorandil; Nifedipine; Propranolol; Rats; Rats, Sprague-Dawley; Sulfones; Tachycardia, Ventricular | 2004 |
A case of recurrent chest pain with reversible left ventricular dysfunction and ST segment elevation on electrocardiogram.
Topics: Acetylcholine; Aged; Cardiac Catheterization; Chest Pain; Cineangiography; Coronary Circulation; Electrocardiography; Female; Humans; Microcirculation; Nicorandil; Nifedipine; Potassium Channels; Syndrome; Vasodilator Agents; Ventricular Dysfunction, Left | 2005 |
Hypoglycemic effect of Belamcanda chinensis leaf extract in normal and STZ-induced diabetic rats and its potential active faction.
Topics: Animals; Blood Glucose; Calcium; Calcium Channels; Diabetes Mellitus, Experimental; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Iridaceae; Male; Nicorandil; Nifedipine; Phytotherapy; Plant Extracts; Plant Leaves; Potassium; Potassium Channels; Rats; Rats, Wistar; Streptozocin | 2011 |
Modeling Congenital Hyperinsulinism with ABCC8-Deficient Human Embryonic Stem Cells Generated by CRISPR/Cas9.
Topics: C-Peptide; Cell Differentiation; Congenital Hyperinsulinism; CRISPR-Cas Systems; Gastrointestinal Agents; Gene Editing; Human Embryonic Stem Cells; Humans; Insulin; Insulin Antagonists; Insulin-Secreting Cells; Models, Biological; Nicorandil; Nifedipine; Octreotide; Phenotype; Potassium Chloride; Sulfonylurea Receptors; Vasodilator Agents | 2017 |